NASDAQ: CPIXCumberland Pharmaceuticals Inc Stock Ownership - Who owns Cumberland Pharmaceuticals?
Insider buying vs selling
Have Cumberland Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Jones | Director | 2025-12-31 | 7 | $3.91 | $27.37Buy |
| Caroline Young | Director | 2025-12-31 | 5 | $3.91 | $19.55Buy |
| A. J. Kazimi | Chairman and CEO | 2025-12-31 | 7 | $3.91 | $27.37Buy |
| Kenneth Krogulski | Director | 2025-12-31 | 62 | $3.91 | $242.42Buy |
| James Jones | Director | 2025-12-30 | 8 | $3.94 | $31.52Buy |
| Caroline Young | Director | 2025-12-30 | 2 | $3.94 | $7.88Buy |
| A. J. Kazimi | Chairman and CEO | 2025-12-30 | 8 | $3.94 | $31.52Buy |
| Kenneth Krogulski | Director | 2025-12-30 | 54 | $3.94 | $212.76Buy |
| James Jones | Director | 2025-12-29 | 8 | $4.01 | $32.08Buy |
| Kenneth Krogulski | Director | 2025-12-29 | 54 | $4.01 | $216.54Buy |
CPIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CPIX insiders and whales buy or sell their stock.
CPIX Shareholders
What type of owners hold Cumberland Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| A. J. Kazimi | 38.12% | 5,701,155 | $22.46M | Insider |
| Millennium Management LLC | 4.00% | 598,634 | $2.36M | Institution |
| Lawrence W. Greer | 3.90% | 583,344 | $2.30M | Insider |
| Ikarian Capital LLC | 3.72% | 555,932 | $2.19M | Institution |
| Renaissance Technologies LLC | 3.45% | 515,465 | $2.03M | Institution |
| Jean W. Marstiller | 2.95% | 440,828 | $1.74M | Insider |
| Robert Edwards | 2.79% | 417,569 | $1.65M | Insider |
| Vanguard Group Inc | 2.75% | 411,786 | $1.62M | Institution |
| Kenneth Krogulski | 1.98% | 296,538 | $1.17M | Insider |
| Dimensional Fund Advisors LP | 1.88% | 280,869 | $1.11M | Institution |
CPIX vs Pharmaceutical Stocks
Cumberland Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.